ctrl K

Watchlist Price Alert

Pasithea Therapeutics Cor... (KTTA)

NASDAQ: KTTA · Real-Time Price · USD

0.72

-0.01 (-1.99%)

At close: Jul 02, 2025, 10:12 AM

Pasithea Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	486.56K	15.06K	n/a
Cost of Revenue	649.03K	648.45K	113.19K	17.27K	n/a
Gross Profit	-649.03K	-648.45K	373.36K	-2.21K	n/a
Operating Income	-14.25M	-15.98M	-14.82M	-4.51M	-40.98K
Interest Income	423.18K	n/a	102.00	508.00	n/a
Pretax Income	-13.9M	-15.51M	-13.94M	-2.17M	-40.98K
Net Income	-13.9M	-15.96M	-13.06M	-2.17M	-40.98K
Selling & General & Admin	6.4M	7.88M	12.52M	4.51M	40.98K
Research & Development	7.2M	8.1M	2.67M	n/a	n/a
Other Expenses	n/a	n/a	44.72K	n/a	n/a
Operating Expenses	13.6M	15.98M	15.19M	4.51M	40.98K
Interest Expense	n/a	n/a	102.00	508.00	n/a
Selling & Marketing Expenses	n/a	-7.87B	2.6M	n/a	n/a
Cost & Expenses	14.25M	15.98M	15.3M	4.52M	40.98K
Income Tax Expense	n/a	n/a	-879.97K	508.00	-61.48K
Shares Outstanding (Basic)	1.1M	1.26M	1.26M	1.15M	688.92K
Shares Outstanding (Diluted)	1.1M	1.23M	1.26M	1.15M	688.92K
EPS (Basic)	-12.69	-12.65	-10.34	-1.89	-0.06
EPS (Diluted)	-12.69	-13.01	-10.34	-1.89	-0.06
EBITDA	-13.26M	-15.33M	-12.58M	-4.51M	n/a
EBIT	-13.9M	-15.98M	-12.59M	-4.51M	-61.48K
Depreciation & Amortization	649.03K	648.45K	5.09K	1.38K	61.48K